MedTrace Logo

3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial

NCT05899270 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-06-12

No results posted yet for this study

Summary

Lung isolation techniques are commonly used to facilitate surgical exposure and to provide single-lung ventilation for patients. We have developed an automatic comparison software for 3D reconstruction based on CT data (3DRACS). It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size and depth of the DLT for lung isolation.The aim of this study was to compare whether the use of 3DRACS to select a DLT size compared to conventional empirical selection methods could improve incidence of DLT intubation success and reduce airway injury.

Conditions

  • Lung Cancer
  • Lung Diseases
  • Tracheal Intubation Morbidity
  • Throat Injury
  • Bronchus; Injury

Interventions

OTHER

3D reconstruction automatic matching system

it is an automatic comparison software for 3D reconstruction based on CT data (3DRACS). It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size and depth of the DLT for lung isolation.

OTHER

traditional method for selecting double lumen tube

In control group, the size of DLT is based on patient's sex and weight and the height is used to guide the depth of DLT insertion.

Sponsors & Collaborators

  • Science and Technology Department of Sichuan Province

    collaborator OTHER

  • Sichuan Cancer Hospital and Research Institute

    lead OTHER

Principal Investigators

  • Yihao Zhu, master · department of anesthesiology, sichuan cancer hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2023-11-30
Completion
2024-03-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05899270 on ClinicalTrials.gov